After two seasons away from NASCAR’s top level, Cole Custer returns to the Cup Series in 2025 as the sole driver for the newly formed Haas Factory Team (HFT). The 2023 Xfinity Series champion ...

Founded by industrialist Gene Haas – owner of Haas Automation, the largest CNC machine tool builder in North America with over 80 outlets globally – MoneyGram Haas F1 Team is headquartered in ...

Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI ...

One team principal agrees, with Haas team boss Ayao Komatsu revealing ... if it is specific or not. “Jet-ski is different. Skiing is different, right? But climbing is different, of course.

Although they've followed very different career paths over the past four decades, founding Kiss stars Gene Simmons and Ace Frehley have used remarkably similar set list formulas on their recent ...

Jesse Kesler had years of positive and personal memories from working as a contractor for Gene Hackman and his wife, Betsy Arakawa Hackman. The owner of MudCity Builders, who worked with the ...

Formula 1 (F1) motor racing team Haas has agreed a new multi-year partnership with Croatia-based cloud communications software firm Infobip. The US-based F1 team - known as MoneyGram Haas F1 ...

Recently, though, it added an unusual new role — as a gene therapy company of sorts. The charity, the Telethon Foundation, took ownership from a small biotech of a drug that has been approved ...

Laura Mueller is part of that club. Working for the Haas F1 team, Mueller is F1's first female race engineer. There are 20 race engineers on the grid, one for each driver. They are the chief link ...

After his first attempt was cut short by weather, Gene Simmons played the first full show of his 2025 solo tour Saturday evening in Beaver Dam, Kentucky. Simmons took some flak for offering a $ ...

Neurocrine Biosciences has handed back two discovery-stage gene therapy programs to Voyager Therapeutics, although the companies’ wider central-nervous-system-focused collaboration remains on track.